Thus, non-cirrhotic grown-up subjects with extreme values of HBV DNA (4.0–8.0 log10 IU/mL) should be considered for antiviral therapy irrespective of their ALT values to additionally decrease the occurrence of HCC [12]. Here, GPT is linked to hepatocellular carcinoma.